Vildagliptin improves high glucose‐induced endothelial mitochondrial dysfunction via inhibiting mitochondrial fission

The dipeptidyl peptidase 4 inhibitor vildagliptin (VLD), a widely used anti‐diabetic drug, exerts favourable effects on vascular endothelium in diabetes. We determined for the first time the improving effects of VLD on mitochondrial dysfunction in diabetic mice and human umbilical vein endothelial c...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Hengdao, Xiang, Hong, Zhao, Shaoli, Sang, Haiqiang, Lv, Fenghua, Chen, Ruifang, Shu, Zhihao, Chen, Alex F., Chen, Shuhua, Lu, Hongwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349192/
https://www.ncbi.nlm.nih.gov/pubmed/30444033
http://dx.doi.org/10.1111/jcmm.13975

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349192/
https://www.ncbi.nlm.nih.gov/pubmed/30444033
http://dx.doi.org/10.1111/jcmm.13975

Ejemplares similares